A Step Forward for Precision Equity in Kidney Disease

Chronic kidney disease (CKD) is a public health problem worldwide. In the United States, for the past four decades, CKD in its most severe form, end-stage kidney failure leading to dialysis or transplantation, limits lifespan and quality of life and has disproportionately affected persons of African descent at four times the rate among White persons.1,2 Effective strategies to disrupt the multifactorial drivers of this health disparity, including environment, lifestyle, access to and quality of care, health and health care policies, and biologic factors, have been elusive.3 Although many experts in health-disparities research hold strong beliefs that one factor trumps others . . .